NO20042769L - Fremgangsmate for a pavise humant papillomavirus-mRNA - Google Patents

Fremgangsmate for a pavise humant papillomavirus-mRNA

Info

Publication number
NO20042769L
NO20042769L NO20042769A NO20042769A NO20042769L NO 20042769 L NO20042769 L NO 20042769L NO 20042769 A NO20042769 A NO 20042769A NO 20042769 A NO20042769 A NO 20042769A NO 20042769 L NO20042769 L NO 20042769L
Authority
NO
Norway
Prior art keywords
human papillomavirus
mrna
showing human
risk
expression
Prior art date
Application number
NO20042769A
Other languages
English (en)
Norwegian (no)
Inventor
Frank Karlsen
Original Assignee
Norchip As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26246916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042769(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0200239A external-priority patent/GB0200239D0/en
Priority claimed from GB0214124A external-priority patent/GB0214124D0/en
Application filed by Norchip As filed Critical Norchip As
Publication of NO20042769L publication Critical patent/NO20042769L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20042769A 2002-01-07 2004-06-30 Fremgangsmate for a pavise humant papillomavirus-mRNA NO20042769L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0200239A GB0200239D0 (en) 2002-01-07 2002-01-07 Method for detecting human papillomavirus mRNA
GB0214124A GB0214124D0 (en) 2002-06-19 2002-06-19 Method for detecting human papillomavirus mRNA
PCT/GB2003/000034 WO2003057914A2 (fr) 2002-01-07 2003-01-07 Methode permettant de detecter l'arn messager du papillomavirus humain

Publications (1)

Publication Number Publication Date
NO20042769L true NO20042769L (no) 2004-10-04

Family

ID=26246916

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042769A NO20042769L (no) 2002-01-07 2004-06-30 Fremgangsmate for a pavise humant papillomavirus-mRNA

Country Status (20)

Country Link
US (4) US7553623B2 (fr)
EP (5) EP2272988A3 (fr)
JP (2) JP4558322B2 (fr)
CN (1) CN100422342C (fr)
AT (1) ATE354677T1 (fr)
AU (2) AU2003201639C1 (fr)
BR (1) BR0306723A (fr)
CA (1) CA2472026A1 (fr)
CY (1) CY1106621T1 (fr)
DE (1) DE60311961T2 (fr)
DK (2) DK1463839T3 (fr)
EA (1) EA006975B1 (fr)
ES (2) ES2654909T3 (fr)
IL (2) IL162722A0 (fr)
MX (1) MXPA04006440A (fr)
NO (1) NO20042769L (fr)
NZ (1) NZ533703A (fr)
PT (1) PT1463839E (fr)
SI (1) SI1463839T1 (fr)
WO (1) WO2003057914A2 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US20110111389A1 (en) * 2001-11-07 2011-05-12 Diagcor Bioscience Incorporation Limited Rapid genotyping analysis for human papillomavirus and the device thereof
EP2272988A3 (fr) 2002-01-07 2011-06-15 Norchip A/S Procédé de détection de mRNA du papillomavirus
EP1369694A1 (fr) * 2002-04-09 2003-12-10 MTM Laboratories AG Procédé de discrimination entre des métaplasies et des lésions néoplastiques ou préneoplastiques
EP1507148B1 (fr) * 2003-08-25 2005-02-23 MTM Laboratories AG Procédé de détection de carcinomes dans des échantillons corporels cervicaux solubilisés
ATE434167T1 (de) * 2003-03-07 2009-07-15 Univ New Jersey Med Optisch dekodierbare mikroträger, arrays und verfahren
US7361460B2 (en) * 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
EP1510820B1 (fr) * 2003-08-25 2010-03-17 MTM Laboratories AG Procédé pour la détection d'états médicalement pertinents dans des échantillons LBC solubilisés
JP4498357B2 (ja) * 2003-09-25 2010-07-07 サード・ウェーブ・テクノロジーズ・インク Ｈｐｖの検出法
WO2005033333A2 (fr) 2003-10-07 2005-04-14 Dako Denmark A/S Methodes et compositions pour le diagnostic de cancer
WO2005062940A2 (fr) 2003-12-22 2005-07-14 John Wayne Cancer Institute Procede et dispositif permettant de prelever et de surveiller in vivo la circulation de composants biologiques
GB0404315D0 (en) * 2004-02-26 2004-03-31 Norchip As Improved detection of human papillomavirus
ITMO20040126A1 (it) 2004-05-21 2004-08-21 Bioanalisi Ct Sud S N C Di Per Sistema per la ricerca ed identificazione di agenti patogeni
EP1809772B1 (fr) 2004-11-09 2013-06-05 Gen-Probe Incorporated Compositions et methode de detection de streptocoques du groupe a
ATE476528T1 (de) 2004-12-08 2010-08-15 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
EP3042963A1 (fr) 2005-06-20 2016-07-13 Advanced Cell Diagnostics, Inc. Procédés de détection d'acides nucléiques dans des cellules individuelles et d'identification de cellules rares dans de grandes populations cellulaires hétérogènes
CA2629564C (fr) * 2005-11-15 2014-04-22 Genoid Kft. Methode de detection de pathogenes
AU2006341730B2 (en) 2006-04-11 2013-04-11 Bio-Rad Innovations HPV detection and quantification by real-time multiplex amplification
US7833716B2 (en) * 2006-06-06 2010-11-16 Gen-Probe Incorporated Tagged oligonucleotides and their use in nucleic acid amplification methods
US20100285443A1 (en) * 2006-12-15 2010-11-11 Oncomethylome Sciences Sa Diagnostic Methods for Diseases Caused by a HPV Infection Comprising Determining the Methylation Status of the HPV Genome
EP3095873B1 (fr) 2006-12-21 2018-04-18 Gen-Probe Incorporated Procédés et compositions pour l'amplification d'acide nucléiques
US7838215B2 (en) * 2007-09-25 2010-11-23 Canvir, Inc. Advanced cervical cell screening methods
JP5299986B2 (ja) * 2007-11-01 2013-09-25 国立大学法人山口大学 核酸の定量方法
CA2704151C (fr) 2007-11-01 2017-04-25 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Nouveau procede de detection de papillomavirus humains du col de l'uterus
JP2011518333A (ja) * 2008-04-17 2011-06-23 キアジェン ゲイサーズバーグ インコーポレイテッド 標的核酸の存在を判別するための合成プローブを用いた組成物、方法、およびキット
US9090948B2 (en) * 2008-09-30 2015-07-28 Abbott Molecular Inc. Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
TWI419974B (zh) 2008-10-27 2013-12-21 Qiagen Gaithersburg Inc 於自動平台上之快速結果雜交捕捉法
EP2184368A1 (fr) 2008-11-07 2010-05-12 DKFZ Deutsches Krebsforschungszentrum Transcription de diagnostic et motifs d'épissage du HPV16 dans différentes lésions cervicales
AU2010242867B2 (en) * 2009-05-01 2016-05-12 Qiagen Gaithersburg, Inc. A non-target amplification method for detection of RNA splice-forms in a sample
EP2478087B1 (fr) * 2009-09-14 2017-01-18 QIAGEN Gaithersburg, Inc. Compositions et méthodes pour la récupération d'acides nucléiques ou de protéines à partir d'échantillons de tissus fixés dans des milieux de cytologie
US8722328B2 (en) * 2010-01-04 2014-05-13 Qiagen Gaithersburg, Inc. Methods, compositions, and kits for recovery of nucleic acids or proteins from fixed tissue samples
JP2013517803A (ja) 2010-01-29 2013-05-20 キアジェン ゲイサーズバーグ インコーポレイテッド サンプル中のｈｐｖの存在を決定および確認する方法
WO2011094514A1 (fr) * 2010-01-29 2011-08-04 Qiagen Gaithersburg, Inc. Procédés et compositions pour la purification et l'analyse multiplexée d'acides nucléiques séquence-spécifique
US20110275698A1 (en) * 2010-05-10 2011-11-10 Norchip A/S "test and treat" strategy for treating transforming hpv infection
EP2572001A2 (fr) 2010-05-19 2013-03-27 QIAGEN Gaithersburg, Inc. Procédés et compositions pour purification séquence-spécifique et analyse multiplex d'acides nucléiques
CA2799205A1 (fr) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Analyse de capture hybride a resultats rapides et sondes associees tronquees de maniere strategique
ES2562821T3 (es) 2010-10-21 2016-03-08 Advanced Cell Diagnostics, Inc. Método ultrasensible para la detección in situ de ácidos nucleicos
CN103517994A (zh) * 2011-01-07 2014-01-15 奇亚根盖瑟斯堡股份有限公司 用于对高风险人乳头瘤病毒进行基因型分型和定量的材料和方法
CN103476948A (zh) * 2011-01-28 2013-12-25 领先细胞医疗诊断有限公司 用于测定头颈癌和宫颈病变中的hpv状态的rnascope* hpv测定法
EP2678442B1 (fr) 2011-02-24 2019-01-16 QIAGEN Gaithersburg, Inc. Matériels et procédés de détection d'acide nucléique de hpv
US20130095474A1 (en) * 2011-10-13 2013-04-18 Joseph Mamone Design of stem-loop probes and utilization in snp genotyping
WO2013067399A1 (fr) 2011-11-03 2013-05-10 Qiagen Gaithersburg, Inc. Substances et procédé pour immobiliser, isoler et concentrer des cellules en utilisant des surfaces carboxylées
CN102864224A (zh) * 2012-09-11 2013-01-09 南京大学 一种血清microRNAs试剂盒及其应用
GB201310933D0 (en) 2013-06-19 2013-07-31 Norchip As A method of cervical screening
CA2932859A1 (fr) * 2013-12-05 2015-06-11 Optipharm. Co., Ltd. Procede de diagnostic ameliore du cancer du col de l'uterus et kit de diagnostic associe
WO2016005789A1 (fr) 2014-07-07 2016-01-14 Institut Pasteur Transcriptome de papillomavirus à large spectre génétique et génotypique en tant que biomarqueur de stades du cancer associé à papillomavirus
CN106048014B (zh) * 2016-06-07 2019-12-10 博奥生物集团有限公司 一种用于实时检测nasba产物的高特异探针
US20190112673A1 (en) * 2017-05-10 2019-04-18 Genomic Vision Association between integration of high-risk hpv genomes detected by molecular combing and the severity and/or clinical outcome of cervical lesions
JP6831772B2 (ja) 2017-12-22 2021-02-17 株式会社Ｓｕｂａｒｕ 画像投影装置
CN114214343A (zh) * 2021-11-15 2022-03-22 上海市东方医院（同济大学附属东方医院） 一组高危型HPV整合所致的宫颈癌中特异表达的mRNA序列

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3779175D1 (de) 1986-03-21 1992-06-25 Pasteur Institut Bestimmte, von einem papillomavirus-genom abgeleitete dns-sequenzen, deren anwendungen fuer in vitro-diagnostische zwecke und die herstellung von antigenzusammensetzungen.
WO1988006634A1 (fr) * 1987-02-26 1988-09-07 The University Of Sydney Procede de detection de papillomavirus humains carcinogenes
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
DE3838269A1 (de) * 1988-11-11 1990-05-17 Behringwerke Ag Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen
US5234809A (en) 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
NL8900725A (nl) 1989-03-23 1990-10-16 Az Univ Amsterdam Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur.
JP2791685B2 (ja) 1989-06-08 1998-08-27 寳酒造株式会社 パピローマウイルスの検出方法
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
DE69022246T2 (de) 1989-12-01 1996-02-29 Amoco Corp Detektion von hpv-transkripts.
NL9000134A (nl) 1990-01-19 1991-08-16 Stichting Res Fonds Pathologie Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5506105A (en) * 1991-12-10 1996-04-09 Dade International Inc. In situ assay of amplified intracellular mRNA targets
AU6945694A (en) * 1993-05-06 1994-12-12 Dade International Inc. Human papillomavirus detection assay
US6174668B1 (en) * 1993-05-14 2001-01-16 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures
EP0728218B1 (fr) 1993-11-12 2008-01-02 PHRI Properties, Inc. Sondes d'hybridation pour la detection d'acides nucleiques, souches universelles, methodes et materiels
DE4431174A1 (de) * 1994-09-01 1996-03-07 Deutsches Krebsforsch Nachweisverfahren für tumorspezifische mRNA
DE19506561C1 (de) * 1995-02-24 1996-10-10 Deutsches Krebsforsch Verfahren zur Früherkennung von HPV-assoziierten Karzinomen bzw. von hochgradigen, durch HPV-verursachten Dysplasien
WO1997018334A2 (fr) 1995-11-15 1997-05-22 Gen-Probe Incorporated Sondes d'acides nucleiques complementaires des acides nucleiques du virus du papillome humain, methodes et preparations associees
US6027981A (en) 1997-10-27 2000-02-22 Texas Instruments - Acer Incorporated Method for forming a DRAM cell with a fork-shaped capacitor
CA2313641A1 (fr) * 1997-12-12 1999-06-24 Digene Corporation Milieu de prelevement universel
WO2000000638A2 (fr) 1998-06-26 2000-01-06 Akzo Nobel N.V. Marquage d'amplicons d'arn produits au moyen d'une amplification fondee sur la transcription
WO2001073135A2 (fr) * 2000-03-28 2001-10-04 Biosearch International Pty. Ltd. Approches permettant de detecter et de classer hpv par stades par ciblage de la region du gene e6 du genome viral
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
GB0018050D0 (en) * 2000-07-21 2000-09-13 Norchip As Detection of human papillomavirus mRNA
DK1421200T3 (da) * 2001-08-23 2007-04-10 Merck & Co Inc Fluoprescerende multiplex HPV PCR-assays under anvendelse af flere fluoroforer
GB0200258D0 (en) * 2002-01-07 2002-02-20 Norchip As Detection of human papillomavirus
EP2272988A3 (fr) 2002-01-07 2011-06-15 Norchip A/S Procédé de détection de mRNA du papillomavirus
GB0404315D0 (en) * 2004-02-26 2004-03-31 Norchip As Improved detection of human papillomavirus

Also Published As

Publication number Publication date
US7553623B2 (en) 2009-06-30
PT1463839E (pt) 2007-05-31
EP2267155A3 (fr) 2011-06-08
JP5204132B2 (ja) 2013-06-05
EP1715062A2 (fr) 2006-10-25
US20090275044A1 (en) 2009-11-05
US20090253124A1 (en) 2009-10-08
EP1715062A3 (fr) 2007-07-11
ES2282599T3 (es) 2007-10-16
SI1463839T1 (sl) 2007-08-31
EA200400919A1 (ru) 2005-02-24
CY1106621T1 (el) 2012-01-25
EP2267155B1 (fr) 2013-03-13
IL162722A (en) 2013-09-30
DE60311961T2 (de) 2007-10-18
EP2913407B1 (fr) 2017-11-01
DE60311961D1 (de) 2007-04-05
US7812144B2 (en) 2010-10-12
EP1715062B1 (fr) 2015-03-11
EP2272988A2 (fr) 2011-01-12
EP1463839B1 (fr) 2007-02-21
AU2003201639B2 (en) 2008-05-15
WO2003057914A2 (fr) 2003-07-17
JP2005514038A (ja) 2005-05-19
MXPA04006440A (es) 2005-03-31
EP2913407A1 (fr) 2015-09-02
AU2008205436A1 (en) 2008-09-04
EP2267155A2 (fr) 2010-12-29
JP2010131020A (ja) 2010-06-17
BR0306723A (pt) 2004-12-21
JP4558322B2 (ja) 2010-10-06
EA006975B1 (ru) 2006-06-30
NZ533703A (en) 2006-05-26
US20050118568A1 (en) 2005-06-02
ES2654909T3 (es) 2018-02-15
DK2913407T3 (en) 2018-01-15
HK1065827A1 (en) 2005-03-04
EP1463839A2 (fr) 2004-10-06
EP2272988A3 (fr) 2011-06-15
DK1463839T3 (da) 2007-07-02
AU2003201639C1 (en) 2009-02-26
US8420314B2 (en) 2013-04-16
AU2003201639A1 (en) 2003-07-24
IL162722A0 (en) 2005-11-20
ATE354677T1 (de) 2007-03-15
CN100422342C (zh) 2008-10-01
US20130309658A1 (en) 2013-11-21
CN1639357A (zh) 2005-07-13
EP2267155B2 (fr) 2016-09-07
WO2003057914A3 (fr) 2004-02-26
CA2472026A1 (fr) 2003-07-17

Similar Documents

Publication Publication Date Title
ATE354677T1 (de) Detektionsverfahren für papillomavirus mrna
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
AU2004205878A8 (en) Gene expression markers for breast cancer prognosis
DE60323300D1 (de) Apparat zur Früherkennung von ischämischen Herzerkrankungen
BR0316969A (pt) Tratamento de mal de huntington com epa
TNSN07036A1 (en) Human monoclonal antibodies against human il-4
WO2005117938A3 (fr) Methodes de traitement des pathologies oculaires
EP1774895A4 (fr) Endoscope et méthode de réparation d'endoscope
AU2003300324A8 (en) Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer
TW200503717A (en) Substituted 1,4-pyrazine derivatives
MX2007002277A (es) Metodos para formar retinoides y usos de los mismos.
DE69916829D1 (de) Genetisch veränderte fibroblasten und ihre verwendung
DE602006009117D1 (de) Verfahren zur identifizierung von die stresstoleranz in hefe erhöhenden genen sowie verwendung dieser gene zur verbesserung von hefestämmen
IS7441A (is) Peptíðdeformýlasatálmar
NO20053829L (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
ATE501278T1 (de) Verfahren zur verwendung von il-21
AU2003281279A1 (en) Method for identifying infection-specific regulated genes of the skin
WO2004007671A3 (fr) Procedes d'identification de composes modulant la synthese d'ige dont le recepteur d'il-4 assure la mediation, au moyen d'une proteine clld8
IL164500A0 (en) 2,5-Bis-diamine-Ä1,4Übenzoquinonic derivatives, useful for the treatment of alzheimers disease, method for disease, method for preparing them and intermediates of said method
IL165626A0 (en) Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
UA51230A (uk) СПОСІБ ДІАГНОСТИКИ ПОШКОДЖЕННЯ S<sub>-3</sub>-СЕГМЕНТІВ ПРОКСИМАЛЬНИХ ВІДДІЛІВ НЕФРОНУ
ITGE20040102A1 (it) Metodo di rasatura e composizione balsamica per l'attuazione di detto metodo.
UA66990A (en) Method for recording latent functional brain pathology in disabled persons in course of their rehabilitation
UA11408U (uk) Спосіб хірургічного лікування хворих на туберкульоз легень

Legal Events

Date Code Title Description
ERR Erratum

Free format text: BLE KUNNGJORT INNKOMMET I PATENTTIDENDE NR 30/04 OG ALLMENT TILGJENGELIG I PATENTIDENDE NR 09/05 MED FEIL INTERNASJONALT SOKNADSNR. RIKTIG INTERNASJONALT SOKNADSNR ER PCT/GB03/00034.

FC2A Withdrawal, rejection or dismissal of laid open patent application